Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

55.2  -0.55 (-0.99%)

Fundamental Rating

6

Overall MELE gets a fundamental rating of 6 out of 10. We evaluated MELE against 54 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making MELE a very profitable company, without any liquidiy or solvency issues. MELE has a valuation in line with the averages, but on the other hand it scores bad on growth. MELE also has an excellent dividend rating. These ratings could make MELE a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year MELE was profitable.
MELE had a positive operating cash flow in the past year.
Of the past 5 years MELE 4 years were profitable.
MELE had a positive operating cash flow in 4 of the past 5 years.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 23.42%, MELE belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
The Return On Equity of MELE (37.69%) is better than 87.04% of its industry peers.
The Return On Invested Capital of MELE (27.13%) is better than 94.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MELE is significantly above the industry average of 16.31%.
The 3 year average ROIC (33.81%) for MELE is well above the current ROIC(27.13%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 23.42%
ROE 37.69%
ROIC 27.13%
ROA(3y)28.86%
ROA(5y)23.4%
ROE(3y)37.54%
ROE(5y)30.95%
ROIC(3y)33.81%
ROIC(5y)27.09%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

1.3 Margins

With a decent Profit Margin value of 21.15%, MELE is doing good in the industry, outperforming 61.11% of the companies in the same industry.
MELE's Profit Margin has been stable in the last couple of years.
The Operating Margin of MELE (26.43%) is better than 66.67% of its industry peers.
MELE's Operating Margin has improved in the last couple of years.
MELE has a worse Gross Margin (44.77%) than 61.11% of its industry peers.
In the last couple of years the Gross Margin of MELE has remained more or less at the same level.
Industry RankSector Rank
OM 26.43%
PM (TTM) 21.15%
GM 44.77%
OM growth 3Y23.02%
OM growth 5Y2.32%
PM growth 3Y16.74%
PM growth 5Y1.39%
GM growth 3Y6.54%
GM growth 5Y0.36%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELE is creating value.
There is no outstanding debt for MELE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 7.43. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.43, MELE is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
MELE has a debt to FCF ratio of 3.41. This is a good value and a sign of high solvency as MELE would need 3.41 years to pay back of all of its debts.
MELE has a Debt to FCF ratio (3.41) which is in line with its industry peers.
A Debt/Equity ratio of 0.43 indicates that MELE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.43, MELE is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.41
Altman-Z 7.43
ROIC/WACC2.61
WACC10.4%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.70 indicates that MELE has no problem at all paying its short term obligations.
MELE has a Current ratio of 4.70. This is amongst the best in the industry. MELE outperforms 88.89% of its industry peers.
A Quick Ratio of 2.02 indicates that MELE has no problem at all paying its short term obligations.
MELE has a better Quick ratio (2.02) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 4.7
Quick Ratio 2.02
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MELE have decreased strongly by -18.34% in the last year.
Measured over the past years, MELE shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.04% on average per year.
EPS 1Y (TTM)-18.34%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-63.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.19%

3.2 Future

The Earnings Per Share is expected to grow by 10.77% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.99% on average over the next years.
EPS Next Y-21.89%
EPS Next 2Y3.73%
EPS Next 3Y6.88%
EPS Next 5Y10.77%
Revenue Next Year-9.53%
Revenue Next 2Y1.72%
Revenue Next 3Y3.86%
Revenue Next 5Y4.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.05 indicates a correct valuation of MELE.
77.78% of the companies in the same industry are more expensive than MELE, based on the Price/Earnings ratio.
MELE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.89.
The Price/Forward Earnings ratio is 16.71, which indicates a correct valuation of MELE.
Based on the Price/Forward Earnings ratio, MELE is valued a bit cheaper than the industry average as 70.37% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MELE to the average of the S&P500 Index (21.98), we can say MELE is valued slightly cheaper.
Industry RankSector Rank
PE 13.05
Fwd PE 16.71
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than MELE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MELE is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 31.99
EV/EBITDA 7.99
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.57
EPS Next 2Y3.73%
EPS Next 3Y6.88%

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.52%, MELE is a good candidate for dividend investing.
MELE's Dividend Yield is rather good when compared to the industry average which is at 1.48. MELE pays more dividend than 100.00% of the companies in the same industry.
MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

On average, the dividend of MELE grows each year by 10.76%, which is quite nice.
Dividend Growth(5Y)10.76%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 71.64% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MELE is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP71.64%
EPS Next 2Y3.73%
EPS Next 3Y6.88%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

More info and screens

MELEXIS NV

EBR:MELE (3/27/2025, 10:43:56 AM)

55.2

-0.55 (-0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)04-30 2025-04-30
Inst Owners16.78%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.23B
Analysts76.67
Price Target67.41 (22.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend3.5
Dividend Growth(5Y)10.76%
DP71.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-5.84%
Max EPS beat(2)9.1%
EPS beat(4)2
Avg EPS beat(4)-1.28%
Min EPS beat(4)-9.25%
Max EPS beat(4)9.1%
EPS beat(8)5
Avg EPS beat(8)0.43%
EPS beat(12)9
Avg EPS beat(12)5.67%
EPS beat(16)11
Avg EPS beat(16)7.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.68%
Revenue beat(4)0
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)5.85%
PT rev (1m)0%
PT rev (3m)-16.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.18%
Valuation
Industry RankSector Rank
PE 13.05
Fwd PE 16.71
P/S 2.26
P/FCF 31.99
P/OCF 14.62
P/B 4.03
P/tB 4.04
EV/EBITDA 7.99
EPS(TTM)4.23
EY7.66%
EPS(NY)3.3
Fwd EY5.99%
FCF(TTM)1.73
FCFY3.13%
OCF(TTM)3.78
OCFY6.84%
SpS24.42
BVpS13.7
TBVpS13.67
PEG (NY)N/A
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 23.42%
ROE 37.69%
ROCE 32.79%
ROIC 27.13%
ROICexc 28.51%
ROICexgc 28.56%
OM 26.43%
PM (TTM) 21.15%
GM 44.77%
FCFM 7.06%
ROA(3y)28.86%
ROA(5y)23.4%
ROE(3y)37.54%
ROE(5y)30.95%
ROIC(3y)33.81%
ROIC(5y)27.09%
ROICexc(3y)43.58%
ROICexc(5y)35.39%
ROICexgc(3y)43.98%
ROICexgc(5y)35.8%
ROCE(3y)40.87%
ROCE(5y)32.75%
ROICexcg growth 3Y9.03%
ROICexcg growth 5Y-4.71%
ROICexc growth 3Y9.58%
ROICexc growth 5Y-4.43%
OM growth 3Y23.02%
OM growth 5Y2.32%
PM growth 3Y16.74%
PM growth 5Y1.39%
GM growth 3Y6.54%
GM growth 5Y0.36%
F-Score3
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.41
Debt/EBITDA 0.77
Cap/Depr 180.13%
Cap/Sales 8.4%
Interest Coverage 28.53
Cash Conversion 49.72%
Profit Quality 33.4%
Current Ratio 4.7
Quick Ratio 2.02
Altman-Z 7.43
F-Score3
WACC10.4%
ROIC/WACC2.61
Cap/Depr(3y)128.48%
Cap/Depr(5y)98.75%
Cap/Sales(3y)6.89%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.34%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-63.41%
EPS Next Y-21.89%
EPS Next 2Y3.73%
EPS Next 3Y6.88%
EPS Next 5Y10.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.19%
Revenue Next Year-9.53%
Revenue Next 2Y1.72%
Revenue Next 3Y3.86%
Revenue Next 5Y4.99%
EBIT growth 1Y5.15%
EBIT growth 3Y52.37%
EBIT growth 5Y13.69%
EBIT Next Year6.33%
EBIT Next 3Y5.74%
EBIT Next 5Y5.87%
FCF growth 1Y-44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.12%
OCF growth 3Y-68.44%
OCF growth 5Y-50.28%